“The development of TE-1182, an ADC for the treatment of HER2-resistant tumors” was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan.
The CDE case number is 115IDX04005.
“The development of TE-1182, an ADC for the treatment of HER2-resistant tumors” was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan.
The CDE case number is 115IDX04005.